拜耳利伐沙班片效果怎么样？

(Rivaroxaban) inhibits thrombosis by inhibiting factor Xa and inhibiting the intrinsic or extrinsic coagulation pathway. It has the following advantages in clinical application: first, it has high bioavailability; second, it is not interfered by food, so it is extremely convenient to use; third, it can be rapidly absorbed after oral administration and excreted through the kidneys in its original form. The application of rivaroxaban in the treatment of patients can significantly improve cardiac function and pulmonary tissue blood perfusion, resulting in significant improvements in blood gas indicators and echocardiographic indicators.

In order to observe the clinical efficacy of rivaroxaban in the treatment of patients with pulmonary embolism, a domestic study selected 92 patients with pulmonary embolism and divided them into a control group (42 cases) and an experimental group (50 cases) according to the random number table method. Patients in the control group were given warfarin treatment; patients in the experimental group were given rivaroxaban treatment. Compare the treatment effects of the two groups.

Results: Comparing the total effective rate after treatment, the total effective rate of the experimental group was higher than that of the control group, and the difference was statistically significant (P ＜ 0.05); comparing the incidence of adverse reactions after treatment, the incidence of adverse reactions in the experimental group was relatively low, and the difference was statistically significant (P ＜ 0.05). It can be seen that the application of rivaroxaban to patients with pulmonary embolism has a high therapeutic effect. The patients' clinical symptoms and blood gas abnormality time can be significantly shortened, and the clinical application value is significant.

Currently, the Bayer Group ranks among the world's top 500 companies, with 750 factories around the world and 120,000 employees. Among Bayer's sub-group businesses, polymers, pharmaceuticals and health care, chemicals and agriculture are the company's four pillar industries. Compared with warfarin, the dosage of Bayer tablets does not need to be adjusted according to the patient's renal function status, age, body weight and gender during the administration period. The risk of bleeding and side effects is significantly lower. There is no need to impose monitoring on coagulation function. It is better tolerated by patients and easier to accept.

Recommended hot articles: /newsDetail/96979.html

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.